Nucleic acid therapeutics: State of the art and future prospects

[41] A comparison of the effect of bcr/abl breakpoint specific phosphothiorate oligodeoxynucleotides on colony formation by bcr/abl positive and negative, CD34 enriched mononuclear cell populations [J]. LEUKEMIA RESEARCH, 1996, 20 (05) : 391 - 395

[42] CHAVANY C, 1995, MOL PHARMACOL, V48, P738

[43] SYNTHESIS OF OLIGODEOXYRIBONUCLEOTIDE N3'-]P5' PHOSPHORAMIDATES [J]. NUCLEIC ACIDS RESEARCH, 1995, 23 (14) : 2661 - 2668

[44] CLARENC JP, 1993, J BIOL CHEM, V268, P5600

[45] POOR CELLULAR UPTAKE OF ANTISENSE OLIGODEOXYNUCLEOTIDES - AN OBSTACLE TO THEIR USE IN CHRONIC MYELOID-LEUKEMIA [J]. LEUKEMIA & LYMPHOMA, 1995, 19 (3-4) : 189 - 195

[46] HIGH-EFFICIENCY RECEPTOR-MEDIATED DELIVERY OF SMALL AND LARGE (48 KILOBASE GENE CONSTRUCTS USING THE ENDOSOME-DISRUPTION ACTIVITY OF DEFECTIVE OR CHEMICALLY INACTIVATED ADENOVIRUS PARTICLES [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (13) : 6094 - 6098

[47] COTTER FE, 1994, ONCOGENE, V9, P3049

[48] ANTISENSE TECHNOLOGY [J]. CURRENT OPINION IN BIOTECHNOLOGY, 1991, 2 (02) : 282 - 287

[49] Crooke Stanley T., 1997, V40, P1

[50] TRANSFER OF GENES TO HUMANS - EARLY LESSONS AND OBSTACLES TO SUCCESS [J]. SCIENCE, 1995, 270 (5235) : 404 - 410

[41] A comparison of the effect of bcr/abl breakpoint specific phosphothiorate oligodeoxynucleotides on colony formation by bcr/abl positive and negative, CD34 enriched mononuclear cell populations [J]. LEUKEMIA RESEARCH, 1996, 20 (05) : 391 - 395

[42] CHAVANY C, 1995, MOL PHARMACOL, V48, P738

[43] SYNTHESIS OF OLIGODEOXYRIBONUCLEOTIDE N3'-]P5' PHOSPHORAMIDATES [J]. NUCLEIC ACIDS RESEARCH, 1995, 23 (14) : 2661 - 2668

[44] CLARENC JP, 1993, J BIOL CHEM, V268, P5600

[45] POOR CELLULAR UPTAKE OF ANTISENSE OLIGODEOXYNUCLEOTIDES - AN OBSTACLE TO THEIR USE IN CHRONIC MYELOID-LEUKEMIA [J]. LEUKEMIA & LYMPHOMA, 1995, 19 (3-4) : 189 - 195

[46] HIGH-EFFICIENCY RECEPTOR-MEDIATED DELIVERY OF SMALL AND LARGE (48 KILOBASE GENE CONSTRUCTS USING THE ENDOSOME-DISRUPTION ACTIVITY OF DEFECTIVE OR CHEMICALLY INACTIVATED ADENOVIRUS PARTICLES [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (13) : 6094 - 6098

[47] COTTER FE, 1994, ONCOGENE, V9, P3049

[48] ANTISENSE TECHNOLOGY [J]. CURRENT OPINION IN BIOTECHNOLOGY, 1991, 2 (02) : 282 - 287

[49] Crooke Stanley T., 1997, V40, P1

[50] TRANSFER OF GENES TO HUMANS - EARLY LESSONS AND OBSTACLES TO SUCCESS [J]. SCIENCE, 1995, 270 (5235) : 404 - 410